EIF2A and thyroid cancer: The active PKR phosphorylated its best substrate eIF2α and consequently inhibited cell proliferation in the immortalized Nthy-ori 3-1 line as well as in a thyroid cancer cell line SW1736 (Figure 2A–2B).